logo
Eli Lilly launches Mounjaro KwikPen for diabetes treatment in India

Eli Lilly launches Mounjaro KwikPen for diabetes treatment in India

Time of India6 days ago
US pharmaceutical major
Eli Lilly
on Wednesday launched its blockbuster diabetes drug Mounjaro in KwikPen, a single patient use prefilled pen designed for once weekly administration-in the Indian market, intensifying competition with rival Danish drugmarker
Novo Nordisk
.
The pen will be available in six dose strengths and the price starts from Rs 14,000 for 2.5 mg dose, Rs 17,500 for 5 mg, Rs 22,000 for 7.5 mg and 10 mg and Rs 27,500 for 12.5 mg and 15 mg dose.
The company said this will allow healthcare professionals to personalize treatment plans to better suit individual patient needs.
'The launch of
Mounjaro KwikPen
marks a step forward in the care of
type 2 diabetes
and obesity, offering a more convenient approach to medication administration." said Winselow Tucker, President and General Manager,
Lilly India
. 'We believe this innovation will support healthcare professionals in delivering more personalized and effective treatment plans, helping to improve outcomes and advance the quality of care for people living with these serious diseases.'
The company has warned against the cosmetic use, reiterating that Mounjaro is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. 'It is not approved for—and must not be used for—cosmetic weight loss'.
'Patients are advised to consult their healthcare professional to determine whether Mounjaro is appropriate for their individual needs,' it further said.
Mounjaro is the first and only dual GIP (glucose- dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, indicated as an adjunct to diet and exercise for the treatment of Type 2 diabetes and chronic weight management in adults with obesity or overweight, with one weight-related comorbidity.
Earlier in March the company launched Mounjaro in 2.5 mg vial and 5 mg vial at Rs 3500 and Rs 4375 respectively. Nearly half of India's 101 million adult patients with diabetes are inadequately treated with suboptimal glycemic control.
Mounjaro reduces body weight and decreases fat mass by regulating appetite.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Howrah to make dog licences mandatory for foreign and mixed-breed pets soon
Howrah to make dog licences mandatory for foreign and mixed-breed pets soon

India Today

timean hour ago

  • India Today

Howrah to make dog licences mandatory for foreign and mixed-breed pets soon

Pet owners of foreign and mixed-breed dogs in West Bengal's Howrah will soon be required to acquire a mandatory licence, as the Howrah Municipal Corporation (HMC) is set to roll out a new pet licencing system in initiative aims to improve the regulation of pet ownership, strengthen public health measures, and curb the spread of diseases, particularly rabies, across the city, officials said. The move follows a similar, successful model implemented by the Kolkata Municipal Chakraborty, the Chief Municipal Administrator of Howrah, announced the new regulations, emphasising that the primary goal is to create a more organised and accountable pet-owning community. "This new rule will first apply to owners of foreign and mixed-breed dogs," he said, also revealing plans to eventually expand the licencing requirement to include pets such as exotic to officials, the licencing system is a critical public health safeguard, as it mandates a current anti-rabies vaccination certificate for each dog. Rabies remains a serious threat, and this measure will enable the HMC to effectively track and control the disease, which can be fatal to both humans and obtain a licence, residents must apply online through the civic body's official website. The application process is designed to be streamlined, requiring the owner's Aadhaar card and the dog's up-to-date vaccination certificate, with a specific focus on the anti-rabies annual fee for the licence is a nominal Rs 150 and must be renewed each year. Chakraborty noted that the corporation will prioritise educating non-compliant owners before taking further decision has received support from some members of the community, while other pet owners have voiced Singh Parmar, a local dog lover and activist, commended the move, stating, "This is a welcome step from the Howrah Municipal Corporation. However, it is vital that these rules are properly enforced, and the government remains diligent."Meanwhile, Piyali Ghosh, who owns a Shih Tzu, acknowledged the positive intent but raised a practical question. "The move is encouraging," she said, "but I wonder if a dog licence truly helps in the search for a lost pet."A public awareness campaign is expected to be launched soon to inform residents about the new rules and the benefits of the licencing system.- EndsTrending Reel IN THIS STORY#West Bengal

Uproar, walkout in House proceedings as HP govt, Opposition clash over HIMCare scheme
Uproar, walkout in House proceedings as HP govt, Opposition clash over HIMCare scheme

Indian Express

time2 hours ago

  • Indian Express

Uproar, walkout in House proceedings as HP govt, Opposition clash over HIMCare scheme

The second day of the monsoon session on Tuesday witnessed multiple disruptions in the state Assembly, with the Opposition members staging walkouts over the Himachal Pradesh government's alleged failure to inform the House about the exact status of the HIMCare health insurance scheme. Heated arguments were exchanged between both sides, with each accusing the other of undermining the democratic values of the House. The uproar began when BJP MLA Vinod Kumar from Nachan sought details about the pending dues under the HIMCare scheme. Although Health Minister Dr (Col) Dhani Ram Shandil informed the House that total pending dues amounted to Rs 364 crore, BJP MLAs alleged that there were incidents where families had to mortgage valuables, including a grandmother's mangalsutra, to pay for medical treatment. Attacking the previous BJP government over the health insurance scheme, Chief Minister Sukhvinder Singh Sukhu said, 'The HIMCare funds were misused, undue benefits were given to private hospitals, and hospital bills were manipulated'. 'The government has released Rs 550 crore for the scheme and henceforth it would be ensured that the needy and poor get the benefit,' the CM said while replying to a question from the BJP member. Sukhu asserted that large-scale irregularities have been detected in the scheme, but still is very much in operation and mapping has been started to improve it. The situation escalated when the Speaker disallowed BJP MLA Vinod Kumar's request to raise the issue as a Point of Order, prompting Opposition leaders to walk out of the House. Speaker Kuldeep Singh Pathania adjourned proceedings for five minutes and appealed to the Opposition to cooperate. He also directed that all undesirable remarks against any minister or member be expunged from the records. Meanwhile, data tabled in the House by Shandil stated that the Himachal government continues to operate the HIMCare health insurance scheme, but official figures reveal a massive pending liability towards hospitals providing services under the programme. According to the government data, an amount of Rs 364.20 crore (Rs 3,64,20,29,707) is yet to be paid to various health institutions across the state for treatments provided under the state insurance scheme. A detailed institution-wise breakup of these dues has been attached to the official records. HIMCare, a flagship health insurance scheme launched to provide affordable healthcare to eligible beneficiaries, offers cashless treatment in both government and empanelled private hospitals. However, the mounting dues have raised concerns among healthcare providers about timely payments and service continuity. The government clarified that in the private sector, only dialysis services have been empanelled under the scheme. Currently, 25 private health facilities are registered exclusively to provide dialysis treatment to patients. A detailed list of these facilities has been appended to the government's official response. The revelation comes amid ongoing discussions in the state about strengthening public healthcare and expanding health insurance coverage. Stakeholders believe that clearing pending payments and empanelling more private services will be crucial for the smooth functioning of HIMCare, especially in remote and rural areas where patients rely heavily on such schemes. Leader of Opposition and former CM Jairam Thakur also expressed concern over the slow pace of restoration in Seraj, which was among the worst-affected regions during this year's natural calamities. 'At least one year will be required to restore full facilities in the disaster-affected Seraj,' he said, adding that road connectivity, public infrastructure, and essential services remain severely impacted. 'Out of 299 water supply lines, 241 were completely damaged in the June 30 natural disaster in my area Seraj. The Irrigation and Public Health (IPH) department led by Deputy CM Mukesh Agnihotri is able to restore 225 water lines temporarily which means that these lines will again be affected after one month. In my point of view, the pace under which the state government has been working, it will take almost one year to restore completely affected basic facilities in the area. Almost 3,000 people were affected only in the Seraj constituency which is the worst affected,' Thakur, who is an MLA from Seraj, said. The former Chief Minister further alleged deep-rooted factionalism within the Public Works Department (PWD), accusing the government of politicising administrative functioning. 'PWD officers in Seraj are divided into two groups — one controlled by the PWD minister and the other by close aides of Chief Minister Sukhvinder Singh Sukhu,' Thakur claimed. Meanwhile, the government has defended its relief efforts, maintaining that restoration works are underway despite challenging terrain and weather conditions. The Himachal Pradesh government has either shut down or de-notified a total of 818 schools across the state over the past three years, citing low or zero student enrolment, state Education Minister Rohit Thakur informed the house on Tuesday. According to a reply submitted by the Education Minister, as of July 31, 2025, these closures were carried out under a state-wide rationalisation policy aimed at ensuring optimal utilisation of teaching staff and infrastructure. Out of these, 535 schools with less than five students have been merged with nearby institutions located within two or three kilometers. The merger and closure process primarily targeted schools in areas where student strength had dropped sharply, making it unviable to maintain separate institutions. Officials said the step was necessary to improve academic standards and streamline resource allocation in the wake of declining enrolment in certain rural belts. District-wise data on these closures and mergers has been compiled under the Education Department's rationalisation plan, which aims to strengthen existing schools by pooling resources and improving teacher-student ratios. The details were supplied in the House on the question of BJP MLA Randhir Sharma of Shri Naina Devi Ji constituency. (With PTI inputs)

Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO
Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO

The Hindu

time2 hours ago

  • The Hindu

Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO

For Indian pharma industry, there is bound to be disruption initially in the event of the U.S. imposing tariff but over time the drugmakers will look to pass on some of the impact to the customers, a top executive of a well known company said. With the U.S. market accounting for a significant part of the portfolio, the industry, however, has to brace for it, Natco Pharma vice-chairman and CEO Rajeev Nannapaneni responded to queries on the impact, in the event of the levy, during an earnings call recently. who had earlier this year highlighted how it is important for drugmakers to get a front-end manufacturing foothold in the U.S. as a counter measure, said the company needs to readjust strategy based on the policy. U.S. is still the most important pharmaceutical market in the world, particularly for some products that account for around two-third of the business. 'You can't ignore 60-70% of the business and run your business,' he said, while pointing out at Natco Pharma's ongoing efforts to build a business outside U.S. The Hyderabad-based firm had recently announced it will be acquiring 36% stake in South African pharmaceutical company Adcock Ingram Holdings (AIHL) for $226 million (around ₹2,000 crore). Over time, the investment will contribute to a 'significant part of our base earnings'... I would believe South Africa will easily be about 15-25% of the base earnings. So we are diversifying away from the U.S. as well. It's not that we are not. But again, you can't ignore U.S. at the same time. So you have to play both the cards,' he said. To another query related on impact of tariffs, sought to explain how it would not be easy to pass through immediately considering the contracts and pricing. But, in the long run, 'we would like to pass it on to our customers because the margins that we work on most of our products are very low. So, there will be some little bit of disruption initially, but I think eventually we will figure out after a quarter.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store